Exane Derivatives’s Tahoe Resources Inc TAHO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-65,607
| Closed | -$239K | – | 727 |
|
|
2018
Q4 | $239K | Sell |
65,607
-263,637
| -80% | -$811K | 0.04% | 228 |
|
|
2018
Q3 | $915K | Buy |
329,244
+325,750
| +9,323% | +$1.26M | 0.17% | 116 |
|
|
2018
Q2 | $17.2K | Buy |
3,494
+3,454
| +8,635% | +$17.4K | ﹤0.01% | 437 |
|
|
2018
Q1 | $188 | Hold |
40
| – | – | ﹤0.01% | 531 |
|
|
2017
Q4 | $191 | Sell |
40
-27,257
| -100% | -$128K | ﹤0.01% | 521 |
|
|
2017
Q3 | $144K | Sell |
27,297
-46,717
| -63% | -$254K | 0.03% | 221 |
|
|
2017
Q2 | $638K | Sell |
74,014
-31,823
| -30% | -$277K | 0.14% | 126 |
|
|
2017
Q1 | $850K | Buy |
105,837
+8,460
| +9% | +$72.9K | 0.19% | 93 |
|
|
2016
Q4 | $917K | Buy |
97,377
+59,761
| +159% | +$623K | 0.18% | 94 |
|
|
2016
Q3 | $483K | Sell |
37,616
-5,041
| -12% | -$74.7K | 0.07% | 155 |
|
|
2016
Q2 | $639K | Buy |
42,657
+32,338
| +313% | +$413K | 0.11% | 112 |
|
|
2016
Q1 | $103K | Buy |
+10,319
| New | +$92.1K | 0.01% | 240 |
|
Exane Derivatives's TAHO Position: Q1 2019 in Review
Exane Derivatives sold out of Tahoe Resources Inc (TAHO) in Q1 2019, closing a stake of 65,607 shares — an estimated $239K sold.
Exane Derivatives first reported a position in TAHO in Q1 2016 and held it in 12 quarters. The position peaked at $917K in Q4 2016. 0 funds tracked by Wall St. Rank hold TAHO as of Q1 2019.
- Exane Derivatives reported no remaining Tahoe Resources Inc position as of Q1 2019 after selling out during the quarter.
- Exane Derivatives sold 65,607 Tahoe Resources Inc shares in Q1 2019, an estimated $239K.
- Exane Derivatives first reported a position in Tahoe Resources Inc in Q1 2016 and held it in 12 quarters.
- Exane Derivatives's Tahoe Resources Inc position peaked at $917K in Q4 2016.
- 0 funds tracked by Wall St. Rank held Tahoe Resources Inc as of Q1 2019.
Based on Exane Derivatives's 13F filing for Q1 2019, filed 24 Apr 2019.